破裂性腹主动脉瘤腔内与开放主动脉修复术后的院内死亡风险
分析2002至2020年全国住院患者样本中13376例破裂性腹主动脉瘤患者,比较开放修复(OAR)与腔内修复(EVAR)的院内死亡率趋势。EVAR组风险调整后生存优势显著(OR 0.39,95%CI 0.32-0.46),且EVAR组院内死亡率随时间显著下降(交互OR 0.96,95%CI 0.95-0.98)。
要点
- EVAR较OAR提供风险调整后生存优势(OR 0.39,95%CI 0.32-0.46)。
- EVAR组院内死亡率随时间显著下降(交互OR 0.96,95%CI 0.95-0.98)。
- OAR与EVAR的生存率均随时间改善。
核心结论
- OAR和EVAR的生存率随时间改善,EVAR在過去20年对破裂性腹主动脉瘤患者持续提供显著生存优势。
研究设计与样本
- 分析2002至2020年全国住院患者样本中13376例接受OAR或EVAR的破裂性腹主动脉瘤患者,评估修复类型和院内死亡率的年度趋势。
- 采用多水平混合效应逻辑回归模型进行患者和系统层面风险调整。
主要发现
- 13376例患者中8357例(62.5%)接受OAR。
- EVAR组患者稍年长(73.7 vs 72.5岁;P < .001),平均Elixhauser指数稍高(4.0 vs 3.8;P < .001)。
- 未调整院内死亡率OAR组为37.4%,EVAR组为22.4%。
- 风险调整后EVAR提供生存优势(OR 0.39;95%CI 0.32-0.46)。
- EVAR组院内死亡率随时间显著下降(交互OR 0.96;95%CI 0.95-0.98)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Observational studies demonstrate reduced mortality after endovascular (EVAR) compared with open aneurysm repair (OAR) for ruptured abdominal aortic aneurysms (rAAAs). We sought to determine national trends in repair type and in-hospital mortality rates for rAAAs. METHODS: We analyzed patients with rAAAs managed with OAR or EVAR from 2002 to 2020 in the National Inpatient Sample and evaluated annual trends in volume and in-hospital mortality by repair type. Multilevel mixed effects logistic regression model was fit for patient and system-level risk adjustment. We assessed interactions between time, sex, and Elixhauser index with repair type. RESULTS: We examined 13,376 patients with rAAAs. Of these, 8357 (62.5%) underwent OAR. Patients receiving EVAR were slightly older (73.7 vs 72.5 years; P < .001) with slightly higher mean Elixhauser index (4.0 vs 3.8; P < .001). Unadjusted in-hospital mortality was 37.4% vs 22.4% for OAR and EVAR, respectively. EVAR offered a risk-adjusted survival advantage (odds ratio [OR], 0.39; 95% confidence interval [CI], 0.32-0.46). There was a statistically significant reduction of in-hospital mortality over time in the EVAR group (interaction OR, 0.96; 95% CI, 0.95-0.98). The interaction between Elixhauser index and repair was not statistically significant (interaction OR, 0.95; 95% CI, 0.87-1.05). CONCLUSIONS: Survival rates for OAR and EVAR improved over time. EVAR persistently provided a substantial survival advantage over OAR in patients with rAAAs over the past 2 decades.
引用
- Daviú-Molinari T, Chin-Bong Choi J, Roberts MC, et al. In-hospital mortality risk after endovascular and open aortic aneurysm repairs for ruptured abdominal aortic aneurysms. J Vasc Surg. 2024. PMID: 39002605. doi:10.1016/j.jvs.2024.07.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。